EcoDrugPlus

Estrogen Receptor 1

Ensembl ID : ENSSDUG00000019116
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSSDUG00000005328
Gene Symbol: ESR2
3 Cross references
208 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSSDUG00000007093
Gene Symbol: LOC111237541
3 Cross references
198 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSSDUG00000002429
Gene Symbol: LOC111220338
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSDUG00000000812
Gene Symbol: XPO1
3 Cross references
223 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSDUG00000017709
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSSDUG00000006385
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSDUG00000015827
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSSDUG00000013303
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSDUG00000006005
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSSDUG00000022853
Gene Symbol: LOC111226155
4 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSSDUG00000004454
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).